drug-eluting coronary stent

drug-e·lut·ing cor·o·nar·y stent

(drŭg'ē-lūt'ing kōr'ŏ-nar-ē stent)
A widely used device with metal surfaces that are coated with a drug to prevent restenosis; used to maintain luminal patency; some study results suggest that when the drug wears off and leaves the bare metal exposed, there is a possibility of acute heart attack and sudden death.
Mentioned in ?
References in periodicals archive ?
today announced that it has completed patient enrollment in its DESSOLVE II CE Mark clinical study of the MiStent Drug-Eluting Coronary Stent System.
Now available in the UK, and implanted for the first time in Europe at Southampton General Hospital, the Resolute Integrity Stent System features a novel drug-eluting coronary stent with superior deliverability - the ability of the device to traverse the patient's vasculature and reach the blockage in the heart artery.
About three-quarters underwent an elective stenting procedure, and slightly more than half received a drug-eluting coronary stent.
has received regulatory approval from Health Canada's Therapeutic Products Directorate (TPD) for use of the Endeavor drug-eluting coronary stent (DES) system in the treatment of coronary artery disease.
Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery.
commercialization of its ZoMaxx(TM) Drug-Eluting Coronary Stent System.
Incorporating Guidant's latest delivery technology promises to improve our current product line and give us entry into the next generation of drug-eluting coronary stent systems earlier than originally anticipated.
DIRECT II is a prospective, randomized, multi-center clinical study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to Medtronic's Resolute Integrity[TM] drug-eluting stent.
today announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation.
The review included 5,342 patients at Prairie Heart who received their first drug-eluting coronary stent during May 2003--December 2006.
The TAXUS Liberte stent is currently the market-leading drug-eluting coronary stent system outside the U.
Abbott (NYSE: ABT) today announced that it will present new data from its SPIRIT family of clinical trials studying the XIENCE(TM) V Everolimus Eluting Coronary Stent System, and the ABSORB trial of the world's first fully bioabsorbable drug-eluting coronary stent, at the EuroPCR meeting May 22-25 in Barcelona, Spain.